Regulus Therapeutics | RGLS - Capital Social Ordinario



Capital Social Ordinario Cambio Fecha
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Alterity Therapeutics Limited AUD 213.97M 144.39K 2023-06
AstraZeneca USD 1.55B 206K 2025-12
Biogen USD 146.7M 200K 2025-09
Celldex Therapeutics USD 66.55M 102K 2025-12
Cipla INR 807.77M 807.43M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
CSL USD 482.13M 93.87M 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Grifols EUR 680.58M 846.11K 2025-12
Immunic USD 8K 4K 2024-06
Incyte USD 198.46M 2.33M 2025-12
Intrexon USD 0 0 2024-06
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Merck USD 2.49B 15.79M 2025-09
Omeros USD 611K 17K 2023-12
Takeda JPY 1.58B 2K 2025-12